Guilherme Corral, DO
Family Medicine · Charlotte, NCNPI 1952938383
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.
Across 46 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$208
- Novo Nordisk$144
- Lilly USA, LLC$140
- Amgen$126
- Shield Therapeutics Inc$109
- Pfizer$99
- plus $158 from 6 others
What the payments were for
- Food & beverage$985100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $208 |
| Novo Nordisk | 8 | $144 |
| Lilly USA, LLC | 7 | $140 |
| Amgen | 8 | $126 |
| Shield Therapeutics Inc | 6 | $109 |
| Pfizer | 5 | $99 |
| Exact Sciences | 2 | $43 |
| Organon | 2 | $40 |
| Viiv Healthcare Company | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
How this compares
$985 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 11 | $107 |
| Atorvastatin Calcium | 16 | $83 |
| Amlodipine Besylate | 12 | $43 |
| Tramadol Hcl | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Charlotte
- Kevin SodenCharlotte$558K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Thomas BarringerCharlotte$138K
- William LarsenCharlotte$74K
- William LongCharlotte$66K
- Steven BauerCharlotte$22K
- Tagbo EkwonuCharlotte$20K
- Rhett BrownCharlotte$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.